Update on cancer chemotherapy: general considerations and breast cancer. Part II.
An update of the state of the art of chemotherapeutic treatment of the late and early stages of breast cancer is described. Important progress has been made in the control of cancer of the breast since the introduction of effective cancer chemotherapy. Of the common tumors, breast cancer is the most responsive to a wide variety of cancer chemotherapeutic agents.Part I of this article (J Natl Med Assoc 77:8 639-647) reviewed the current use of cancer chemotherapeutic agents in general in the treatment of common types of cancer and the use of hormone therapy in the treatment of breast cancer. Part II describes the use of nonhormonal treatment of breast cancer.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008875:Middle Aged; D010052:Ovariectomy; D011897:Random Allocation; D013629:Tamoxifen / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013629:Tamoxifen